GPC BIOTECH

GPC Biotech is a German biopharmaceutical company that discovers and develops anticancer drugs. The company’s product portfolio includes Satraplatin, a platinum-based small molecule for prostate cancer; MAb 1D09C3, a monoclonal antibody for lymphoma; and RGB-286199, a small molecule for refractory cancer. In March 2000, the company acquired Mitotix, Inc., an American drug discovery and development company focused on treatments for cancer and fungal infections. GPC Biotech was founded in 1997 and currently operates as a subsidiary of Agennix AG.